Article | October 11, 2022

Maximizing Oncology Study Outcomes: Protocol Development Considerations

Source: Premier Research

By Ashley Herrick and Nicole Carswell

GettyImages-1332585814-oncology-patient-cancer

Minimizing the burden that trial participants experience is essential for successful recruitment and retention, especially in oncology studies, where patients may need to be followed for years after the treatment phase of the trial. For sponsors, the process of optimizing study outcomes involves a deep understanding of the patient’s care journey and a deliberate effort to incorporate patient-gathered insights into trial design.

In this blog post, we explore protocol development considerations to reduce patient burden and enhance the overall clinical trial experience.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader